| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023309 |
| Receipt No. | R000026859 |
| Scientific Title | Retrospective Investigation of CT and MRI Imaging Features of Tubulocystic Renal Cell Carcinoma. |
| Date of disclosure of the study information | 2016/08/01 |
| Last modified on | 2019/07/27 (Ver. 4) |
| Basic information | ||
| Public title | Retrospective Investigation of CT and MRI Imaging Features of Tubulocystic Renal Cell Carcinoma. | |
| Acronym | Retrospective Investigation of CT and MRI Imaging Features of Tubulocystic Renal Cell Carcinoma. | |
| Scientific Title | Retrospective Investigation of CT and MRI Imaging Features of Tubulocystic Renal Cell Carcinoma. | |
| Scientific Title:Acronym | Retrospective Investigation of CT and MRI Imaging Features of Tubulocystic Renal Cell Carcinoma. | |
| Region |
|
|
| Condition | |||
| Condition | Tubulocystic Renal Cell Carcinoma(TC-RCC), Collecting Duct Carcinoma(CDC), Papillary Renal Cell Carcinoma(P-RCC), Multilocular Cystic Renal Cell Carcinoma(MC-RCC), Cystic Nephroma(CN), Mixed Epithelial and Stromal Tumor of Kidney(MEST) | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To clarify the CT and MR imaging features for Tubulocystic Renal Cell Carcinoma. |
| Basic objectives2 | Others |
| Basic objectives -Others | The same as purpose 1. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Imaging features of Tubulocystic Renal Cell Carcinoma in comparison with Collecting Duct Carcinoma, Papillary Renal Cell Carcinoma, Multilocular Cystic Renal Cell Carcinoma, Cystic nephroma, and Mixed Epithelial and Stromal Tumor of Kidney. Descriptively summarize the following evaluation items on CT and MRI images among tumors; diameter, borderline, internal structure, necrosis, bleeding, invasion, calcification, venous tumor thrombus, dynamic pattern, CT index, Low intensity of T2, T2 STAR or SWI, observation of T1 in-opposed phase, observation of DWI,
pathological staging, Bosniak classfication |
| Key secondary outcomes | Not applicable. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients(Pts.) histopathologically diagnosed as TC-RCC, CDC, MC-RCC, CN, MEST from Jan 2005 to Mar 2016.
2. Pts. histopathologically diagnosed as P-RCC from Jan 2015 to Dec 2015. 3. Pts. Who were performed MDCT and / or MRI, followed resection within 6 months. 4. Pts. histopathologically definitive diagnosed. 5. Acceptable regardless of hospitalization, outpatient. 6. Acceptable regardless of gender. |
|||
| Key exclusion criteria | 1. Pts. before surgery for renal tumors receiving chemotherapy surgery within six months ago.
2. Pts. receiving chemotherapy for renal tumors after CT or MRI. 3. Double registration of the same patient is prohibited. 4. Any other pts. who are determined ineligible for this study by investigators. |
|||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Institute and Graduate School of Biomedical Sciences. Hiroshima University | ||||||
| Division name | Department of diagnostic radiology | ||||||
| Zip code | 7340037 | ||||||
| Address | Hiroshima | ||||||
| TEL | +81822575257 | ||||||
| honday@hiroshima-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Institute and Graduate School of Biomedical Sciences. Hiroshima University | ||||||
| Division name | Department of diagnostic radiology | ||||||
| Zip code | 7340037 | ||||||
| Address | Kasumi 1-2-3, minami-ku, Hiroshima, Japan | ||||||
| TEL | 082-257-5257 | ||||||
| Homepage URL | |||||||
| honday@hiroshima-u.ac.jp | |||||||
| Sponsor | |
| Institute | Institute and Graduate School of Biomedical Sciences. Hiroshima University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Bayer Yakuhin |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Center of integrated medical research. Hiroshima University |
| Address | 1-2-3 Kasumi Minami-Ku |
| Tel | +81822575257 |
| kasumi-kenkyu@office.hiroshima-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Imaging features of Tubulocystic Renal Cell Carcinoma in comparison with Collecting Duct Carcinoma, Papillary Renal Cell Carcinoma, Multilocular Cystic Renal Cell Carcinoma, Cystic nephroma, and Mixed Epithelial & Stromal Tumor of Kidney. Descriptively summarize the following evaluation items on CT and MRI images among tumors; diameter, borderline, internal structure, necrosis, bleeding, invasion, calcification, venous tumor thrombus, dynamic pattern, CT index, Low intensity of T2, T2 STAR or SWI, observation of T1 in-opposed phase, observation of DWI,
pathological staging, Bosniak classfication |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000026859 |